Institute of Science Tokyo · Graduate School of Health Sciences

Research keywordsbreast cancer biomarkers・hormone receptor signaling・protein interactions・ovarian carcinoma・somatostatin receptors・epithelial-mesenchymal transition

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Iwabuchi E, Suzuki T, Ikeda K, Shibuya Y, Shigeta S, Shimada M, Horie K, Inoue S. Immunoreactivities of ZCCHC3 and Efp in the high-grade serous and clear cell ovarian carcinomas are worse prognostic factors 2026.02; 76 (2): e70096. ( DOI )2026
• Kento Iida, Erina Iwabuchi, Yasuhiro Miki, Koki Hasegawa, Yasuyo Ohi, Yoshiaki Rai, Yasuaki Sagara, Takanori Ishida, Hironobu Sasano, Takashi Suzuki. Detection of Somatostatin Receptors by Ligand Derivative Staining in Breast Tumors. Anticancer Res. 2025.08; 45 (8): 3221-3230. ( PubMed , DOI )2025
• Erina Iwabuchi, Yasuhiro Miki, Junyao Xu, Ayako Kanai, Takanori Ishida, Takashi Suzuki. Tetraspanins CD63 and CD81 as potential prognostic biomarkers in breast cancer. Breast cancer. 2025.01; 32 (2): 393-403. ( PubMed , DOI )2025
• Nattamolphan Wittayavimol, Erina Iwabuchi, Prangwan Pateetin, Yasuhiro Miki, Yoshiaki Onodera, Hironobu Sasano, Viroj Boonyaratanakornkit. Progesterone receptor-Grb2 interaction is associated with better outcomes in breast cancer. The Journal of steroid biochemistry and molecular biology. 2024.03; 237 106441. ( PubMed , DOI )2024

• Official profile